What question did this study set out to answer?

This research aims to evaluate how the renin-angiotensin system influences aldosterone secretion during sodium restriction in normal individuals.

October 1, 1978The Journal of Clinical Endocrinology & Metabolism

Adrenal Responses to Pharmacological Interruption of the Renin-Angiotensin System in Sodium-Restricted Normal Man*

View Full Paper

Ask AI

Bookmark

Why the study?

Does pharmacological interruption of the renin-angiotensin system reduce plasma aldosterone levels in sodium-restricted normal subjects?

Key Points

This research aims to evaluate how the renin-angiotensin system influences aldosterone secretion during sodium restriction in normal individuals.
Two pharmacological agents, saralasin (an angiotensin II antagonist) and SQ 20881 (a converting enzyme inhibitor), were administered.
The study involved 62 normal subjects with a focus on the dose-related effect on plasma aldosterone levels after sodium restriction.
Dose-response relationships for saralasin were established at two different infusion durations.
Saralasin reduced aldosterone levels by -10.1 +/- 3.8 ng/dl (P < 0.025) at an optimal dose of 0.1 microgram/kg/min after 20 minutes.
A 3-hour infusion of saralasin resulted in a greater reduction of -15 +/- 4 ng/dl (P < 0.01).
SQ 20881 caused a significant decrement in aldosterone levels by -6.5 +/- 1.5 ng/dl (P < 0.01) at 0.1 mg/kg, reaching a maximum of -10 +/- 3 ng/dl.

Structured PICO

Does pharmacological interruption of the renin-angiotensin system reduce plasma aldosterone levels in sodium-restricted normal subjects?

Population

62 normal subjects with sodium restriction

Intervention

Pharmacological interruption of the renin-angiotensin system using saralasin (0.03-1.0 microgram/kg/min infusion for 20 min or 3 hours) or SQ 20881 (0.1-0.3 mg/kg)

Outcome

Plasma aldosterone levelssurrogate

Pharmacological interruption of the renin-angiotensin system decreases aldosterone secretion in sodium-restricted normal subjects, supporting the hypothesis that angiotensin mediates the adrenal response to sodium restriction.

Limitations

Saralasin is a partial agonist
SQ 20881 induces an increase in plasma renin activity via interruption of the short feedback loop

Discussion

No takes yet. Share an insight, caveat, or question.

Implication

Supports angiotensin mediation of aldosterone response to sodium restriction in normals; hypothesis-generating and leaves clinical translation open.

Cite This Study

Williams et al. (1978) studied this question.

synapsesocial.com/papers/6a22729914901001fcff5d42 https://doi.org/10.1210/jcem-47-4-725

View Full Paper

Ask AI

Bookmark

Implication

Supports angiotensin mediation of aldosterone response to sodium restriction in normals; hypothesis-generating and leaves clinical translation open.

Adrenal Responses to Pharmacological Interruption of the Renin-Angiotensin System in Sodium-Restricted Normal Man*

Key Points

Structured PICO

Limitations

Discussion

Implication

Cite This Study

Adrenal Responses to Pharmacological Interruption of the Renin-Angiotensin System in Sodium-Restricted Normal Man*

Key Points

Structured PICO

Limitations

Discussion

Implication

Cite This Study

Also Consider

Also Consider